Valcyte.com site quick analysis
Share your opinion about Valcyte.com:
Search engine results page snippet (SERP)
This is how Valcyte.com appears when you search for it:
valcyte.com
Learn how to reduce Valcyte® (valganciclovir hydrochloride) costs and how Valcyte antiviral medication can help prevent CMV disease in transplant patients. Indications. Adult patients: Valcyte® (valganciclovir hydrochloride) tablets are an antiviral prescription medication given to patients who have a high chance of developing cytomegalovirus (CMV) disease after receiving a heart, kidney, or kidney‐pancreas transplant. Valcyte helps prevent CMV disease in these patients. Pediatric Patients: Valcyte tablets or oral solution is prescribed for the prevention of CMV disease in patients that are 4 months to 16 years of age who have received a kidney transplant or in patients that are 1 month to 16 years of age who have received a heart transplant and have a high chance of developing CMV disease. Important Safety Information and Most Serious Side Effects. Valcyte can affect blood cells and bone marrow causing serious and life‐threatening problems. Patients’ doctors may do regular blood tests to check blood cells and may change the dose or tell patients to stop taking Valcyte. Patients must tell their doctor right away if they have any unexpected bruising or bleeding, unusual tiredness, fever, lack of energy, dizziness, or fainting. Valcyte may cause cancer. Valcyte causes cancer in animals. It is not known if Valcyte causes cancer in people. Valcyte may cause birth defects. Pregnant women who take Valcyte have a higher chance of having a baby with birth defects. Valcyte should not be used during pregnancy. Women who can get pregnant must use a reliable method of birth control during treatment with Valcyte and continue birth control for at least 30 days after they stop taking Valcyte. Women must tell their doctor right away if they get pregnant or plan to become pregnant while taking Valcyte. Men must use a condom during treatment with Valcyte, and for at least 90 days after treatment, if their partner can get pregnant. Patients should talk to their doctor if they have questions about birth control. Valcyte may lower the amount of sperm in a man’s body and cause fertility problems. Valcyte may also cause fertility problems in women. Do not take Cytovene‐IV if you are taking VALCYTE. You could overdose and become very sick if VALCYTE is taken with Cytovene‐IV. Talk to your healthcare provider or pharmacist if you have questions about your medicine. Patients should not receive Valcyte if they are allergic to any of its ingredients or if they have ever had a serious reaction to ganciclovir capsules or Cytovene‐IV. Symptoms of an allergic reaction to Valcyte may include cold, sudden trouble breathing, wheezing, hives all over the body, swelling around the mouth, or feeling anxious. Valcyte can affect the kidneys, including serious problems such as kidney failure. The patient’s doctor may do regular blood tests to check kidney function while patients are taking Valcyte. The doctor may adjust the dose based on these tests. Patients must not take Valcyte tablets if they are receiving hemodialysis. Patients should talk to their doctor if they are receiving hemodialysis. Before starting Valcyte, patients should tell their doctor if they: are pregnant or plan to become pregnant. It is not known if Valcyte causes birth defects in an unborn baby, are breast feeding, or plan to breast feed, have kidney problems or any other medical condition, have problems with their blood cells, are taking any prescription or non‐prescription medicines, vitamins, and herbal supplements, are having radiation treatment, are receiving hemodialysis. Valcyte can cause seizures, sleepiness, dizziness, unsteady movements, and confusion. Patients should not drive a car or operate other dangerous machinery until they know how Valcyte affects them. Patients must take Valcyte exactly as their doctor prescribes it. Adult patients should use Valcyte tablets, not Valcyte for oral solution. Valcyte must be taken with food. Do not break or crush tablets. Common side effects of Valcyte in adults and children include: diarrhea, nausea, vomiting, fever, shaky movements (tremors), low blood cell counts in a blood test, and rejection of the transplanted organ (graft). Other common side effects in children include: headache, upper respiratory tract infection, high blood pressure, and urinary tract infection. Patients should tell their doctor if they have any side effect that bothers them or that does not go away. Patients should call their doctor for medical advice about side effects. Consumers may report side effects to the FDA at 1‐800‐FDA‐1088 or to Genentech at 1‐888‐835‐2555. Please see full Prescribing Information, including Boxed WARNINGS and Medication Guide, for additional Important Safety Information.
General website information
A quick breakdown about the Valcyte.com website can be found further down:
Aspect | Summary |
---|
Website load speed: | 2.152s poor |
Number of (outgoing) links: | 34 |
HTML size: | 30.4 kilobytes Good |
Valcyte.com HTTP headers
HTTP/1.1 200 OK
Date: Tue, 16 May 2017 16:17:55 GMT
Content-Disposition: inline;filename="index.html"
Accept-Ranges: bytes
ETag: /patient_1491862759053
Last-Modified: Mon, 10 Apr 2017 22:19:19 GMT
Content-Range: bytes 0-31173/31173
Content-Length: 31173
Keep-Alive: timeout=1, max=100
Connection: close
Content-Type: text/html;charset=UTF-8
Content-Language: en
Set-Cookie: BIGipServerws_products_pool=!FDh/gMJuM4QkAtXhZrY1cYfRyoiyAwXYn1kTIaRm1di9HOq5hMBIDBJebWtLIlSLPq4l68P4V5JokQ==; path=/
IP address in detail
The following domains are, too, hosted on 72.34.128.99:
Keywords
A total of 17 keywords are used by the website
- patient financial support
- organ transplants
- valcyte
- cytomegalovirus
- antiviral
- transplant
- cmv virus
- CMV
- GTAS
- Genentech
- co-pay card
- valcyte cost
- patient assistance
- genentech transplant access services
- valganciclovir hydrochloride
- generic valcyte
- cytomegalovirus antiviral
List of related IP addresses
Based on A and B block, the following IP adresses are similar to 72.34.128.99
Domain extension options
The following domain extensions are available for the domain name, with a total of 730 variations available:
Global Alexa rating
As mentioned by Alexa on their official page, the Alexa rank or rating is calculated using a number of different parameters, such as daily average of unique visitors as well as pageviews over the last three months. The more unique visitors and pageviews, the higher the overall rank.
Unfortunately, our database contains no Alexa rank data for Valcyte.com at this time.
Website domain mistypes
Visitors frequently mistype valcyte.com.
Here is a list of most common misspellings:
Domain history
It seems valcyte.com has only been registered once and was never abandoned or has never expired.
Rating by Quantcast
Established in 2006, the technology company Quantcast provides audience measurements and an opportunity for advertising in real time. In addition to that, the American company ensures public access to all sorts of website-related data (traffic and demographic) for millions of websites, as well as in-depth user insights to digital bloggers and publishers enrolled in Quantcast's Quantified Publisher Program. The processing capability provided by Quantcast is impressive – over 800 thousand transactions per second, with, as claimed by the company, accurate audience calculation for over 100 million online destinations. In 2013, Quantcast was widely believed to be among the top five of world's largest data processing companies. Holding offices in London, Dublin, New York and Chicago, the main headquarters of Quantcast is in San Francisco, CA.
Valcyte.com
Current rating: | spotted 3,747 days ago |
---|
Worst rating: | spotted 3,753 days ago |
---|
Best rating: | spotted 3,777 days ago |
---|
Average rating: | |
---|